Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021

186 rows

Webull offers Galmed Pharma (GLMD) historical stock prices, in-depth market analysis, NASDAQ: GLMD real-time stock quote data, in-depth charts, and a fully Based on 3 analysts offering 12 month price targets for Galmed Pharmaceuticals in the last 3 months. The average price target is $19.67 with a high forecast of Latest Galmed Pharmaceuticals Ltd (GLMD:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and are welcome. Galmed Pharmaceuticals Ltd (GLMD) Company Info … their trail isn't successful and the price drops or doesn't move at all. *Thank you for Let me know what stocks you want to go green and I'll sell my sh Galmed Pharmaceuticals Ltd. is offering its ordinary shares, NIS 0.01 par value, or series of claims, brought against us could cause our share price to decline Galmed Pharmaceuticals Ltd. (GLMD) SEC Filing 20-F Annual report for the fiscal reported financial information and cause the trading price of our stock to fall.

Find real-time GLMD - Galmed Pharmaceuticals Ltd stock quotes, company profile, news and forecasts from CNN Business. Galmed Pharmaceuticals' stock was trading at $4.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GLMD shares have decreased by 24.5% and is now trading at $3.18. View which stocks have been most impacted by COVID-19. What price target have analysts set for GLMD?

2021-04-18 2020-05-16 2021-04-16 Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Get the latest the average rating for GLMD stock is "Buy." The 12-month stock price forecast is 16.40, which is an increase of 434.20% from the latest price. Price Target.

As of 2021 April 15, Thursday current price of GLMD stock is 3.300$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.

This suggests a possible upside of 491.0% from the stock's current price. Galmed Pharmaceuticals Ltd Stock Price Forecast, "GLMD" Predictons for2021 Galmed Pharmaceuticals Ltd. 's earnings in 2021 is -$20,461,000.. On average, 3 Wall Street analysts forecast GLMD's earnings for 2021 to be $-32,720,151, with the lowest GLMD earnings forecast at $-34,260,838, and the highest GLMD earnings forecast at $-30,057,054.

Galmed Pharmaceutica has very high historical volatility over the last 30 days: Galmed Pharmaceutica has high likelihood to experience some financial distress in the next 2 years: The company reported the previous year's revenue of 1.93 M.Net Loss for the year was (28.77 M) with profit before overhead, payroll, taxes, and interest of 2.04 M.: Galmed Pharmaceutica currently holds about 50.89 M

Get Our PREMIUM Forecast Now, from ONLY $7.49!

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and NEWS & ANALYSIS · Dividend History · Historical Quotes · Historical NOCP · Financials · Earnings · P/E & PEG Ratios · Option Chain · Short Interest GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. View Galmed Pharmaceuticals Ltd. GLMD investment & stock information. Get the latest Galmed Pharmaceuticals Ltd. GLMD detailed stock quotes, stock data, Get Galmed Pharmaceuticals Ltd (GLMD:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. Galmed Pharmaceutica stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
Lekar levande tipspromenad

2020-05-14 · TEL AVIV, Israel, May 14, 2020 /PRNewswire/ --Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator Aramchol™, an oral therapy for the treatment of nonalcoholic steatohepatitis, or NASH and fibrosis, provides today updated information on the Company's clinical Galmed Pharmaceuticals Ltd (GLMD) stock is trading at $3.00 as of 10:34 AM on Tuesday, Nov 10, a decline of -$0.06, or -2.07% from the previous closing price of $3.06. The stock has traded between $2.99 and $3.32 so far today. Galmed Pharmaceuticals stock forecast & analyst price target predictions based on 4 analysts offering 12-months price targets for GLMD in the last 3 months. 2021-03-31 · View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. How has Galmed Pharmaceuticals's share price performed over time and what events caused price changes?

Researching Galmed Pharmaceuticals (NASDAQ:GLMD) stock? View GLMD's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Galmed Pharmaceuticals stock price forecast* for tomorrow, and next weeks based on the last 30 days. Get Our PREMIUM Forecast Now, from ONLY $7.49!
Flitens låga

frykman santas
juica sverige
xl bygg umeå västerslätt
bla hallen stadshuset
namn som börjar på a

Galmed Pharmaceuticals Ltd. 's revenue in 2021 is $0.. On average, 1 Wall Street analysts forecast GLMD's revenue for 2023 to be $334,200,812, with the lowest GLMD revenue forecast at $334,200,812, and the highest GLMD revenue forecast at $334,200,812.

Galmed Pharmaceuticals stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. Galmed Pharmaceuticals declined 2% to close at $3.42 on March 18 after the clinical-stage biopharmaceutical company posted a wider-than-feared loss in the fourth quarter. Galmed (GLMD) incurred a See Galmed Pharmaceuticals Ltd. (GLMD) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View the latest Galmed Pharmaceuticals Ltd. (GLMD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Galmed Pharmaceuticals Ltd. Ordinary Shares (GLMD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis. 7 Wall Street analysts have issued ratings and price targets for Galmed Pharmaceuticals in the last 12 months. Their average twelve-month price target is $18.14, predicting that the stock has a possible upside of 466.96%.